INSIGHTS

Introduction Intellectual property refers to the creation of mind, wherein a person uses his intellect to create unique works such as...

Introduction - Examination of witnesses or cross-examination has always been a favourite topic for books and screenplays. A downside of...

Khurana & Khurana, Advocates and IP Attorneys (K&K) along with its IP Asset Management Practice, IIPRD , are happy to announce that...

Applicability of order XIII-A of CPC to Intellectual Property Dispute With the objective of streamlining and expediting the disposal of...

Technically YES . The Patents Act, 1970 (hereinafter referred to as the “Act”) is a piece of legislation, penalties under which are...

With business models over the world turning more idea-driven, Intellectual Property Rights (IPRs) are now one of the most valuable assets...

In Teva Parenteral Medicines, Inc.; APP Pharmaceuticals LLC; Pliva Hrvatska D.O.O.; Teva Pharmaceuticals USA, Inc.; and Barr...

Anjana Mohan, an intern at Khurana & Khurana, Advocates and IP Attorneys deals with the updates in the Patent Litigation between Dolby...

In Amgen v. Apotex (No. 2016-1308), the US Court of Appeals for the Federal Circuit on July 5, 2016 affirmed a district court’s ruling...

The High Court of Delhi has passed an interim order wherein the  Justices have made it clear that the appellant (Glenmark) may use any...

A company sets different price for its products for different countries as per the requirements. Parallel Imports come about when there...

Patent Litigation in India has steadily increased over the last 2-3 years. Dramatic swift has been observed in the innovator’s...

Reportedly, Hon’ble Supreme Court of India on Special Leave Petition filed by Glenmark stayed the Delhi High Court order which passed...

Reportedly, a bench of Delhi High Court temporarily allowed Xiaomi to sell few of its devices in India about a week after the suspension...

Applicant in this case is M/s Air Master Equipments India (P) Ltd and Respondents are: Mr. Ramesh Nana Mhatre, who is the inventor and...

In a latest update, Novartis has sued Cipla for infringing its patents on “Onbrez” (Indacaterol) after Cipla lunched its generic version...

As reported in TOI , the Indian Government has found very little merit in Cipla’s plea for waiver and cancellation of Patent rights for...

In CS(OS)  3775/2014, as we understand from multiple sources, Xiaomi has been injuncted from manufacturing its line of smart phones for...

It has been recently reported in Economic times that Cipla has filed representation with the government (Department of Industrial Policy...

In a recent judgment, The U.S. Court of Appeals for the Federal Circuit on July 25, 2014, vacated the U.S. District Court's decision on...